N-[(5S,7S,10S,17R,20R)-10-benzyl-20-methyl-17-(2-methylpropyl)-2,8,15,18-tetraoxo-12,22-dioxa-3,9,16,19,24,25-hexazatetracyclo[19.2.1.111,14.03,7]pentacosa-1(23),11(25),13,21(24)-tetraen-5-yl]-3H-benzimidazole-5-carboxamide
C37H39N9O7 — CID 154565537
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(5S,7S,10S,17R,20R)-10-benzyl-20-methyl-17-(2-methylpropyl)-2,8,15,18-tetraoxo-12,22-dioxa-3,9,16,19,24,25-hexazatetracyclo[19.2.1.111,14.03,7]pentacosa-1(23),11(25),13,21(24)-tetraen-5-yl]-3H-benzimidazole-5-carboxamide
N-[(5S,7S,10S,17R,20R)-10-benzyl-20-methyl-17-(2-methylpropyl)-2,8,15,18-tetraoxo-12,22-dioxa-3,9,16,19,24,25-hexazatetracyclo[19.2.1.111,14.03,7]pentacosa-1(23),11(25),13,21(24)-tetraen-5-yl]-3H-benzimidazole-5-carboxamide (PubChem CID 154565537) has the molecular formula C37H39N9O7 and a molecular weight of 721.78 g/mol. Its IUPAC name is N-[(5S,7S,10S,17R,20R)-10-benzyl-20-methyl-17-(2-methylpropyl)-2,8,15,18-tetraoxo-12,22-dioxa-3,9,16,19,24,25-hexazatetracyclo[19.2.1.111,14.03,7]pentacosa-1(23),11(25),13,21(24)-tetraen-5-yl]-3H-benzimidazole-5-carboxamide.
Molecular Properties
| Compound Name | N-[(5S,7S,10S,17R,20R)-10-benzyl-20-methyl-17-(2-methylpropyl)-2,8,15,18-tetraoxo-12,22-dioxa-3,9,16,19,24,25-hexazatetracyclo[19.2.1.111,14.03,7]pentacosa-1(23),11(25),13,21(24)-tetraen-5-yl]-3H-benzimidazole-5-carboxamide |
|---|---|
| PubChem CID | 154565537 |
| Molecular Formula | C37H39N9O7 |
| Molecular Weight | 721.78 g/mol |
| Exact Mass | 721.30 |
| IUPAC Name | N-[(5S,7S,10S,17R,20R)-10-benzyl-20-methyl-17-(2-methylpropyl)-2,8,15,18-tetraoxo-12,22-dioxa-3,9,16,19,24,25-hexazatetracyclo[19.2.1.111,14.03,7]pentacosa-1(23),11(25),13,21(24)-tetraen-5-yl]-3H-benzimidazole-5-carboxamide |
| SMILES | CC(C)C[C@H]1NC(=O)c2coc(n2)[C@H](Cc2ccccc2)NC(=O)[C@@H]2C[C@H](NC(=O)c3ccc4nc[nH]c4c3)CN2C(=O)c2coc(n2)[C@@H](C)NC1=O |
| InChI | InChI=1S/C37H39N9O7/c1-19(2)11-26-32(48)40-20(3)35-45-29(17-52-35)37(51)46-15-23(41-31(47)22-9-10-24-25(13-22)39-18-38-24)14-30(46)34(50)43-27(12-21-7-5-4-6-8-21)36-44-28(16-53-36)33(49)42-26/h4-10,13,16-20,23,26-27,30H,11-12,14-15H2,1-3H3,(H,38,39)(H,40,48)(H,41,47)(H,42,49)(H,43,50)/t20-,23+,26-,27+,30+/m1/s1 |
| InChIKey | HZNGNKAYQXUXGH-ORJBLZHMSA-N |
| XLogP | 2.99 |
| TPSA | 217.45 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 721.78 |
| LogP ≤ 5 | 2.99 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154565537 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.